Lawmakers Ask DOJ, FTC to Examine Optum’s Amedisys Transaction

Sen. Elizabeth Warren (D-Massachusetts) and Rep. Pramila Jayapal (D-Washington) have called on the U.S. Justice Department (DOJ) and the Federal Trade Commission (FTC) to “scrutinize” the pending acquisition of Amedisys (NASDAQ: AMED) by Optum Health. Optum, a subsidiary of UnitedHealth Group (NYSE: UHN), in June penned its agreement to acquire Amedisys in an all-cash transaction […]

Amedisys Shareholders Approve Sale to Optum

Shareholders of Amedisys Inc. (NASDAQ: AMED) have voted in favor of the company’s pending acquisition by the UnitedHealth Group (NYSE: UNH) subsidiary Optum. Optum in June penned a deal to acquire Amedisys in an all-cash transaction of $101 per share, or about $3.3 billion. The transaction followed a previous offer to acquire Amedisys by the […]

How Contessa’s Palliative Care Business Factored Into the Amedisys-Optum Transaction

Negotiations around Amedisys Inc.’s (NASDAQ: AMED) Contessa subsidiary were a significant contributor to the pendulum swing that led to the company’s acquisition by UnitedHealth Group’s (NYSE: UNH) Optum rather than Option Care Health (NASDAQ: OPCH). Optum in June penned its agreement to acquire Amedisys in an all-cash transaction of $101 per share, or about $3.3 […]

Regulatory Pressures Contributing to M&A Slump

Regulatory challenges have contributed to the hospice sector’s current M&A slump, but this year’s volume nevertheless aligns with experts’ forecasts. In addition to those pressures, the industry is also in a cooling period in which companies focus on integrating the assets that many acquired during flurries of activity in 2021 and 2022, according to Mark […]

[UPDATED] Optum Swoops in to Buy Amedisys in $3.3 Billion Transaction

The UnitedHealth Group (NYSE: UNH) subsidiary Optum has penned a deal to acquire Amedisys (NASDAQ: AMED) in an all-cash transaction of $101 per share, or about $3.3 billion. The pending transaction followings a previous offer to aquire Amedisys by the home infusion company Option Care Health (NASDAQ: OPCH) for $3.6 billion. “We are excited about […]

Minority Investor Pushing for Enhabit Sale

A minority investor in Enhabit Inc. (NYSE: EHAB) is urging the hospice and home health provider to consider a “full and fair sale process.” The investor – New York-based hedge fund AREX Capital Management, which holds about 4.5% of the shares of Enhabit – brought up the sale idea in a letter sent to the […]

4 For-Profit Hospice Providers to Watch in 2023

The hospice space — and the health care system at large — is in a state of flux, driven by value-based reimbursement models, an expanding home-based care continuum and industry-changing transactions. Halfway through the year, Hospice News’ “Four Providers to Watch,” exemplifies the ways that hospice operators are trying to not only to keep up […]

Option Care, Amedisys Deal Reveals a ‘Whole Different Landscape’ for Hospice Providers

The implications of Option Care Health’s (NASDAQ: OPCH) pending $3.6 billion acquisition of Amedisys Inc. (NASDAQ: AMED) reflect rapidly changing market forces that could affect the industry at large. The rationale behind the transaction rests on four pillars, Option Care executives recently indicated — value-based reimbursement, the importance of scale in payer negotiations, a desire […]

4 Pillars Underlying the Amedisys, Option Care Health Transaction

The rationale behind Option Care Health’s (NASDAQ: OPCH) $3.6 billion acquisition of Amedisys Inc. (NASDAQ: AMED) is built on four pillars — vastly expanded scale, value-based payment, data collection capabilities and a desire to outpace a rapidly evolving health care environment. As Amedisys Chairman Paul Kusserow said in a February earnings call, “Change creates opportunities.” […]

[UPDATED] Amedisys to Merge with Infusion Services Provider Option Care Health in $3.6 Billion Deal

In a $3.6 billion all-stock transaction, the home- and alternate-site infusion services company Option Care Health (NASDAQ: OPCH) will acquire Amedisys Inc. (NASDAQ: AMED).  Based on 2022 financial results, the combined companies earned roughly $6.2 billion, with adjusted EBITDA approaching $622 billion. Together, they would have a combined workforce of 16,500. Option Care CEO John […]